{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:29:14Z","timestamp":1793820554229,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571709"],"award-info":[{"award-number":["81571709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971650"],"award-info":[{"award-number":["81971650"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34291","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T20:05:40Z","timestamp":1720555540000},"page":"e34291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Shikonin inhibits the growth of anaplastic thyroid carcinoma cells by promoting ferroptosis and inhibiting glycolysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Chen","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-878X","authenticated-orcid":false,"given":"Zhaowei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e34291_bib1","first-page":"800","article-title":"Anaplastic thyroid cancer: HOW far can we go?","volume":"19","author":"Amaral","year":"2020","journal-title":"Excli Journal"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34291_bib2","first-page":"15","article-title":"Anti-anaplastic thyroid cancer (ATC) effects and mechanisms of PLX3397 (pexidartinib), a multi-targeted tyrosine kinase inhibitor (TKI)","volume":"15","author":"Luo","year":"2023","journal-title":"Cancers"},{"issue":"5930","key":"10.1016\/j.heliyon.2024.e34291_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Heiden","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34291_bib4","doi-asserted-by":"crossref","first-page":"13906","DOI":"10.1080\/21655979.2022.2086378","article-title":"Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway","volume":"13","author":"Dai","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34291_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41467-020-18020-8","article-title":"GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heliyon.2024.e34291_bib6","doi-asserted-by":"crossref","first-page":"S822","DOI":"10.1245\/s10434-015-4730-x","article-title":"Both GLUT-1 and GLUT-14 are independent prognostic factors in gastric adenocarcinoma","volume":"22","author":"Berlth","year":"2015","journal-title":"Ann. Surg Oncol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34291_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34291_bib8","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/cas.13380","article-title":"Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3","volume":"108","author":"Shintoku","year":"2017","journal-title":"Cancer Sci."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e34291_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e34291_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fmicb.2021.663481","article-title":"Thioredoxin reductase is a valid target for antimicrobial therapeutic development against gram-positive bacteria","volume":"12","author":"Felix","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.heliyon.2024.e34291_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.redox.2023.102703","article-title":"The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1","volume":"62","author":"Cheff","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.heliyon.2024.e34291_bib12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2147\/IJN.S401570","article-title":"Promising nanomedicines of shikonin for cancer","volume":"18","author":"Yan","year":"2023","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.heliyon.2024.e34291_bib13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.freeradbiomed.2014.02.016","article-title":"Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells","volume":"70","author":"Duan","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34291_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41392-022-00888-1","article-title":"Characterization of a small-molecule inhibitor targeting NEMO\/IKK beta to suppress colorectal cancer growth","volume":"7","author":"Yu","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34291_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappa B signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34291_bib16","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41374-021-00606-5","article-title":"MicroRNA-182 improves spinal cord injury in mice by modulating apoptosis and the inflammatory response via IKK beta\/NF-kappa B","volume":"101","author":"Fei","year":"2021","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34291_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-kappa B signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34291_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.molcel.2012.09.028","article-title":"EGFR-induced and PKC epsilon monoubiquitylation-dependent NF-kappa B activation upregulates PKM2 expression and promotes tumorigenesis","volume":"48","author":"Yang","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.heliyon.2024.e34291_bib19","first-page":"149","article-title":"Pharmacological properties and derivatives of shikonin-A review in recent years","author":"Guo","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e34291_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153805","article-title":"Shikonin, a naphthalene ingredient: therapeutic actions, pharmacokinetics, toxicology, clinical trials and pharmaceutical researches","volume":"94","author":"Sun","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.heliyon.2024.e34291_bib21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2019.04.033","article-title":"Shikonin derivatives for cancer prevention and therapy","volume":"459","author":"Boulos","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.heliyon.2024.e34291_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2017.01.008","article-title":"SIRT2 mediated antitumor effects of shikonin on metastatic colorectal cancer","volume":"797","author":"Zhang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34291_bib23","first-page":"661","article-title":"Shikonin inhibites migration and invasion of thyroid cancer cells by downregulating DNMT1","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34291_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1530\/EC-16-0105","article-title":"Anti-tumor effects of shikonin derivatives on human medullary thyroid carcinoma cells","volume":"6","author":"Hasenoehrl","year":"2017","journal-title":"Endocrine Connections"},{"key":"10.1016\/j.heliyon.2024.e34291_bib25","first-page":"15","article-title":"Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34291_bib26","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.30467","article-title":"Induction of oxidative stress through inhibition of thioredoxin reductase 1 is an effective therapeutic approach for hepatocellular carcinoma","volume":"69","author":"Lee","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34291_bib27","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41418-019-0399-1","article-title":"SLC27A5 deficiency activates NRF2\/TXNRD1 pathway by increased lipid peroxidation in HCC","volume":"27","author":"Gao","year":"2020","journal-title":"Cell Death Differ."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024103222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024103222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:35:15Z","timestamp":1773840915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024103222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":27,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024103222"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34291","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shikonin inhibits the growth of anaplastic thyroid carcinoma cells by promoting ferroptosis and inhibiting glycolysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34291"}}